Obesema 1.7mg Injection

Obesema 1.7 mg Injection contains semaglutide which is a Glucagon-like peptide-1 (GLP-1) receptor agonist. It helps to regulate appetite and blood sugar levels. It is usually prescribed as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management.

Key Features

How does Obesema 1.7 mg work?

The active ingredient in Obesema 1.7 mg is Semaglutide that works in the body through following pathways:

• Glucose control: Semaglutide stimulates glucose-dependent insulin secretion and decreases glucagon secretion to prevent the liver from producing too much sugar. 
• Appetite suppression: It acts on the brain’s hypothalamus to increase the feeling of fullness and reduce food cravings. 
• Slower gastric emptying: Semaglutide reduces the rate at which the stomach digests the food and prevents post-meal sugar spike. 

Directions for use

Obesema 1.7 mg injection is for subcutaneous use only and should be administered by a healthcare professional. It should be injected in places like the upper thigh, abdomen and upper arm. Do not self-administer without training. 

Dosage

Use as and when prescribed by the healthcare provider. 

Uses

Obesema 1.7 mg injection is used for:

• Weight management
• Cardiovascular risk management
• Diabetes mellitus
• Weight related comorbid conditions

Side effects

• Headache
• Drowsiness
• Constipation
• Nausea
• Vomiting
• Severe hypersensitivity
• Redness, pain and itching at the site of administration
• Reduced appetite
• Vision changes
• Pancreatitis

Interactions

• Obesema may increase the risk of low blood sugar when used with insulin  or sulfonylureas.
• Since it slows down bowel emptying, it can affect how some oral medications work.
• Certain antibiotics and antimalarial drugs like clarithromycin, hydroxychloroquine can compound stomach side effects or alter blood sugar. 
• Avoid herbal supplements like gymnema, bitter melon or fenugreek as it can cause blood sugar drop. 
• Long term use of steroids may interact with semaglutide and disturb the bone forming benefits of the medication. 

Precautions & Warnings

• Semaglutide may cause dehydration due to nausea, vomiting, or diarrhea. Maintain adequate fluid intake during treatment. 
• Semaglutide has a warning for the risk of thyroid C-cell tumours. 
• Do not use the product if you are allergic to Semaglutide or any other ingredient of the product.
• This medication is not recommended if pregnant or while breast feeding. 
• If you are allergic to semaglutide do not use the injection. 
• Use with caution if you have severe stomach problems like gastroparesis.
• Do not share the pens between users even if the needle is changed.
• If you are planning for pregnancy, stop using the product at least 2 months before conceiving. 
• Store the pen as instructed and keep it out of children and pets.
• It is not recommended for patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a genetic disorder that increases the risk of thyroid cancer. 
• Inform your healthcare provider about all prescription medicines, over-the-counter drugs, herbal supplements, and vitamins you are taking. 

Conclusion

Obesema 1.7 mg Injection is an injection that works by enhancing insulin secretion, reducing excess glucagon and slowing gastric emptying which promotes the feeling of fullness and lowers calorie intake. Always consult your healthcare provider before starting the treatment. Do not self-administer and take precautions. 

FAQ’s